Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             40 results found
no title author magazine year volume issue page(s) type
1 A Critical Perspective on the Role of Catheter Ablation in Management of Atrial Fibrillation Wyse, D. George
2013
29 10 p. 1150-1157
8 p.
article
2 Adopting the New Anticoagulants: All Aboard or All in Good Time? Deyell, Marc W.
2013
29 10 p. 1295-1298
4 p.
article
3 Antiarrhythmic Drugs in Atrial Fibrillation: Do They Have a Future? Angaran, Paul
2013
29 10 p. 1158-1164
7 p.
article
4 A Single Bout of High-Intensity Interval Exercise Does Not Increase Endothelial or Platelet Microparticles in Stable, Physically Fit Men With Coronary Heart Disease Guiraud, Thibaut
2013
29 10 p. 1285-1291
7 p.
article
5 Atrial Fibrillation and Congestive Heart Failure: A Cost Analysis of Rhythm-Control vs Rate-Control Strategies Poulin, Frédéric
2013
29 10 p. 1256-1262
7 p.
article
6 Atrioventricular Heart Block and Syncope Coincident With Diagnosis of Systemic Lupus Erythematosus Prochaska, Micah T.
2013
29 10 p. 1330.e5-1330.e7
1.3167000001E10 p.
article
7 Coronary Air Embolism Associated With Atrioesophageal Fistula After Ablation of Atrial Fibrillation Shim, Chi Young
2013
29 10 p. 1329.e17-1329.e19
1.31571E22 p.
article
8 Cost-Effectiveness of Dronedarone in Patients With Atrial Fibrillation in the ATHENA Trial Berg, Jenny
2013
29 10 p. 1249-1255
7 p.
article
9 Echocardiographic Assessment of Cardiac Performance in Response to High Altitude and Development of Subclinical Pulmonary Edema in Healthy Climbers Pagé, Maude
2013
29 10 p. 1277-1284
8 p.
article
10 Editorial Board 2013
29 10 p. A1-
1 p.
article
11 Esophagitis and Atrial Fibrillation: Association or Risk Factor Turagam, Mohit K.
2013
29 10 p. 1330.e15-
1 p.
article
12 Flecainide or Propafenone vs Vernakalant for Conversion of Recent-Onset Atrial Fibrillation Conde, Diego
2013
29 10 p. 1330.e13-
1 p.
article
13 Genetic Modifier of the QTc Interval Associated With Early-Onset Atrial Fibrillation Andreasen, Laura
2013
29 10 p. 1234-1240
7 p.
article
14 How to Optimize Rate Control in Clinical Atrial Fibrillation Management Andrade, Jason G.
2013
29 10 p. 1299-1301
3 p.
article
15 Information for Readers 2013
29 10 p. A12-
1 p.
article
16 Lone Atrial Fibrillation in the Pediatric Population Mills, Lindsay C.
2013
29 10 p. 1227-1233
7 p.
article
17 Management of Atrial Fibrillation in the Year 2033: New Concepts, Tools, and Applications Leading to Personalized Medicine Gillis, Anne M.
2013
29 10 p. 1141-1146
6 p.
article
18 Mass in the Left Atrial Appendage: A Therapeutic Dilemma Natarajan, Arun
2013
29 10 p. 1329.e13-1329.e15
1.31571E18 p.
article
19 Paroxysmal Atrial Fibrillation and Pulmonary Veins: Relationships Between Clinical Forms and Automatic Versus Re-entrant Mechanisms Nattel, Stanley
2013
29 10 p. 1147-1149
3 p.
article
20 Percutaneous Closure of a Very Large Left Atrial Appendage Using the Amplatzer Amulet Freixa, Xavier
2013
29 10 p. 1329.e9-1329.e11
1.31571000000001E14 p.
article
21 Recent-Onset Atrial Fibrillation in Patients With Left Ventricular Dysfunction: Amiodarone or Vernakalant? Conde, Diego
2013
29 10 p. 1330.e11-1330.e12
1.197000000000001E15 p.
article
22 Relationship of Quality of Life With Procedural Success of Atrial Fibrillation (AF) Ablation and Postablation AF Burden: Substudy of the STAR AF Randomized Trial Mantovan, Roberto
2013
29 10 p. 1211-1217
7 p.
article
23 Resveratrol Protects Against Functional Impairment and Cardiac Structural Protein Degradation Induced by Secondhand Smoke Exposure Arcand, Steven
2013
29 10 p. 1320-1328
9 p.
article
24 Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis Shurrab, Mohammed
2013
29 10 p. 1203-1210
8 p.
article
25 Self-Expandable Device for Percutaneous Closing of Left Atrial Appendage With Organized Thrombus in a Patient With Permanent Atrial Fibrillation Pak, Hui-Nam
2013
29 10 p. 1329.e1-1329.e3
1.315711E6 p.
article
26 Successful Percutaneous Aspiration Thrombectomy for Acute Mesenteric Ischemia in a Patient With Atrial Fibrillation Despite Optimal Anticoagulation Therapy Kim, Boo-Gyoung
2013
29 10 p. 1329.e5-1329.e7
1.3157100001E10 p.
article
27 Table of Contents 2013
29 10 p. A3-
1 p.
article
28 Tachycardia-Induced Cardiomyopathy Unmasked With Implantable Cardioverter Defibrillator Implantation Danon, Asaf
2013
29 10 p. 1330.e9-1330.e10
1.1970000000001E13 p.
article
29 Targeted Ablation at Stable Atrial Fibrillation Sources Improves Success Over Conventional Ablation in High-Risk Patients: A Substudy of the CONFIRM Trial Baykaner, Tina
2013
29 10 p. 1218-1226
9 p.
article
30 Temporal Trends in Medication Use and Outcomes in Atrial Fibrillation Pilote, Louise
2013
29 10 p. 1241-1248
8 p.
article
31 The Emerging Role of Biomarkers in Atrial Fibrillation Kornej, Jelena
2013
29 10 p. 1181-1193
13 p.
article
32 The Evolving Role of Stroke Prediction Schemes for Patients With Atrial Fibrillation Ha, Andrew
2013
29 10 p. 1173-1180
8 p.
article
33 The Relationship Among Atrium Electromechanical Interval, Insulin Resistance, and Metabolic Syndrome Hung, Chung-Lieh
2013
29 10 p. 1263-1268
6 p.
article
34 Transient Myocardial Tissue and Function Changes During a Marathon in Less Fit Marathon Runners Gaudreault, Valerie
2013
29 10 p. 1269-1276
8 p.
article
35 Unique Quantitative Trait Loci in Synergy Permanently Improve Diastolic Dysfunction Chauvet, Cristina
2013
29 10 p. 1302-1309
8 p.
article
36 Upregulation of Nox4 Promotes Angiotensin II-Induced Epidermal Growth Factor Receptor Activation and Subsequent Cardiac Hypertrophy by Increasing ADAM17 Expression Zeng, Si-Yu
2013
29 10 p. 1310-1319
10 p.
article
37 Value of Magnetic Resonance Imaging in Guiding Atrial Fibrillation Management Han, Frederick T.
2013
29 10 p. 1194-1202
9 p.
article
38 Ventricular Fibrillation Associated With J-Wave Manifestation Following Pericarditis After Catheter Ablation for Paroxysmal Atrial Fibrillation Kimura, Takehiro
2013
29 10 p. 1330.e1-1330.e3
1.316701E6 p.
article
39 Which Oral Anticoagulant for Which Atrial Fibrillation Patient: Recent Clinical Trials and Evidence-Based Choices Cairns, John A.
2013
29 10 p. 1165-1172
8 p.
article
40 Who Should (or Should Not) Be Considered for Catheter Ablation of Atrial Fibrillation? Andrade, Jason G.
2013
29 10 p. 1292-1294
3 p.
article
                             40 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands